Acute heart failure in an adult with unrecognized congenital heart disease
Submitted: December 9, 2015
Accepted: December 9, 2015
Published: December 9, 2015
Accepted: December 9, 2015
Abstract Views: 1113
PDF: 419
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Paola Maria Medusa , Marina Gilli, Luca Notizia, Raffaella Pagliaro, Nicola Carro, Alessandro Moriello, Vito D'Agnano, Andrea Bianco, Fabio Perrotta, Fabiana Vitiello, Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Matteo Vitacca, Anna Giardini, Lidia Gazzi, Michele Vitacca, Hidden biases in clinical decision-making: potential solutions, challenges, and perspectives , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
You may also start an advanced similarity search for this article.